Un cambio de paradigma que llega para quedarse - Sauri Gudlavalleti habla con el gerente de
14 de septiembre de 2020
Sauri Gudlavalleti, director global de la Organización de Desarrollo de Productos Integrados (IPDO), el Dr. Reddy's habló con el Gerente de CME sobre el cambio de paradigma en I+D farmacéutico por la pandemia del COVID-19.
Para leer el artículo, haga clic aquí< /fuerte>
Descargo de responsabilidad
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.